You appear to be offline. Some data may be unavailable until your connection is restored.

ABBV

Stock

AbbVie Inc.

Create price alert

Description

AbbVie Inc. is a global specialty biopharmaceutical company that discovers, develops, manufactures and markets medicines for complex and serious diseases, focusing on therapeutic areas such as immunology, oncology, neuroscience, eye care and aesthetics. Its business model relies on a portfolio of patented biologics and small‑molecule drugs—including well‑known products like Humira, Imbruvica and Botox—supported by contract manufacturing services and worldwide commercial operations. Formed in 2012 as a spin‑off from Abbott Laboratories, AbbVie is among the largest biomedical firms by revenue and is a component of major U.S. indices, reflecting a strong market position in the pharmaceutical sector.

Dividend

3.00% annual yield
quarterly payout
Ex-Dividend: Jul 16, 2026 (est.)
Payment: Aug 14, 2026 (est.)
Dividend history
Amount Ex-Date Payment Date
$1.73 Apr 15, 2026 May 15, 2026
$1.73 Jan 16, 2026 Feb 17, 2026
$1.64 Oct 15, 2025 Nov 14, 2025

Track every ABBV dividend

Get reminders ahead of ABBV's ex-dividend and payment dates, so you always know when distributions are coming. Pair them with price and earnings alerts to keep your full income picture in view.